Skip to search formSkip to main contentSkip to account menu

Chronic Myelomonocytic Leukemia-2

Known as: CMML-2 
A chronic myelomonocytic leukemia characterized by the presence of 10-19 percent blasts in the bone marrow and 5-19 percent blasts in the peripheral… 
National Institutes of Health

Related topics

Related topics

21 relations
AgranulocytosisAnemiaBone MarrowBone marrow stem cell

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Chronic myelomonocytic leukemia coexisting with monoclonal gammopathy: concomitant response to azacitidine of both disorders
2014
2014
Allogeneic Transplantation for Chronic Myelomonocytic Leukemia (CMML) Is Associated with High Disease-Free Survival Even in the Setting of High-Risk Disease
Background: CMML has a poor prognosis with a median overall survival of about 30 months and a 15-20% risk of transformation to… 
Review
2013
Review
2013
Chronic myelomonocytic leukemia: myelodysplastic or myeloproliferative?
2013
2013
Screening for IDH mutations in chronic myelomonocytic leukemia
Recent genome-wide sequencing eff orts have led to the identifi cation of a number of new candidate genes involved in the… 
2013
2013
Massive gastrointestinal bleeding during the course of chronic myelomonocytic leukemia.
We report the case of a 75-year-old male patient with chronic myelomonocytic leukemia-2 (CMML-2), who developed massive lower… 
2010
2010
Analyses of 81 Chronic Myelomonocytic Leukemia (CMML) for EZH2, TET2, ASXL1, CBL, KRAS, NRAS, RUNX1, IDH1, IDH2, and NPM1 Revealed Mutations In 86.4% of All Patients with TET2 and EZH2 Being of High…
Abstract 296 Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic malignancy that is characterized by features of… 
2010
2010
Plasmacytoid dendritic cell nodules in bone marrow biopsies of chronic myelomonocytic leukemia
These are the bone marrow aspirate and biopsy findings in a 61-year-old woman who presented with anemia and thrombocytopenia. The… 
2010
2010
A Phase I Study of ENMD-2076 In Patients with Relapsed or Refractory Leukemia
Abstract 3307 Background: ENMD-2076 is a novel, orally-active molecule that inhibits Aurora A kinase and FLT3, as well as… 
2007
2007
Lenalidomide as induction therapy before allogeneic stem cell transplantation in a patient with proliferative CMML-2 and del(5q) not involving the EGR1 locus
Myelodysplastic syndromes (MDSs) comprise a heterogeneous group of disorders. Recently, the WHO (World Health Organization… 
2005
2005
[Chronic myelomonocytic leukemia with pleural effusion as the first clinical sign].
We report a chronic myelomonocytic leukemia (CMML) patient whose initial symptom was pleural effusion, which is extremely rare. A… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)